Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Agudelo-Romero (Perth (WA), Australia), K. Martinovich (Perth (WA), Australia), J. Chandler (Atlanta (GA), United States of America), K. Ling (Perth (WA), Australia), E. Sutanto (Perth (WA), Australia), D. Jones (Atlanta (GA), United States of America), R. Tirouvanzium (Atlanta (GA), United States of America), S. Stick (Perth (WA), Australia), L. Garratt (Perth (WA), Australia), A. Kicic (Perth (WA), Australia), W. Erp (Perth (WA), Australia), A. Cf (Perth (WA), Australia). Using integrated omics to assess the effects of rhinovirus infection in children with Cystic Fibrosis (CF).. 4342

Member's Comments

No comment yet.

Related content which might interest you: Rhinovirus infections in the upper and lower airways of young Australian children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Differential interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Evolution of the infectious disease in cystic fibrosis (CF) Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 Systemic quorum sensing signal molecules are biomarkers for current and future P. aeruginosa infection in cystic fibrosis patients: A longitudinal study Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment? Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 LATE-BREAKING ABSTRACT: Is there a relationship between use of inhaled antibiotics and prevalence of fungal isolates in the respiratory secretions of people with cystic fibrosis? A retrospective data analysis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Whole metagenome shotgun sequencing analysis of microbiome of cystic fibrosis- and COPD patients Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF) Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013 Cystic Fibrosis Lung disease, from animal models to experimental therapeutics. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015 Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Hypoglycemia: An unrecognized problem in cystic fibrosis (CF) patients unmasked by continues glucose monitorisation (CGM) Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Lung clearance index (LCI) and trapped gas (TG) may reflect different aspects of Cystic Fibrosis (CF) lung disease in infants Source: Eur Respir J 2003; 22: Suppl. 45, 228s Year: 2003 Current concepts: host–pathogen interactions in cystic fibrosis airways disease Source: Eur Respir Rev 2014; 23: 320-332 Year: 2014 Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis Source: Eur Respir J 2015; 45: 1748-1751 Year: 2015